Cholera risk factors
|
Cholera Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholera risk factors On the Web |
|
American Roentgen Ray Society Images of Cholera risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]
Overview
Certain factors have been found to be associated with an increased risks of Cholera. Among these decreased immunity, decreased gastric pH, certain blood groups (Blood group O are most prone, blood group AB is least prone), and genetics are the commonest associated.
Risk Factors
Blood Group
- Recent epidemiologic research suggests that an individual's susceptibility to cholera (and other diarrheal infections) is affected by their blood type: Those with type O blood are the most susceptible,[1][2] while those with type AB are the most resistant. Between these two extremes are the A and B blood types, with type A being more resistant than type B.
Genetics
- It has also been hypothesized that the cystic fibrosis genetic mutation has been maintained in humans due to a selective advantage: heterozygous carriers of the mutation (who are thus not affected by cystic fibrosis) are more resistant to V. cholerae infections.[3] In this model, the genetic deficiency in the cystic fibrosis transmembrane conductance regulator channel proteins interferes with bacteria binding to the gastrointestinal epithelium, thus reducing the effects of an infection.
Decreased Gastric Acidity
- Use of antacids
Decreased Immunity
- Malnourished patients
References
- ↑ Swerdlow D, Mintz E, Rodriguez M, Tejada E, Ocampo C, Espejo L, Barrett T, Petzelt J, Bean N, Seminario L (1994). "Severe life-threatening cholera associated with blood group O in Peru: implications for the Latin American epidemic". J Infect Dis. 170 (2): 468–72. PMID 8035040.
- ↑ Harris J, Khan A, LaRocque R, Dorer D, Chowdhury F, Faruque A, Sack D, Ryan E, Qadri F, Calderwood S (2005). "Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity". Infect Immun. 73 (11): 7422–7. PMID 16239542.
- ↑ Bertranpetit J, Calafell F (1996). "Genetic and geographical variability in cystic fibrosis: evolutionary considerations". Ciba Found Symp. 197: 97–114, discussion 114-8. PMID 8827370.